Market Chatter: GSK Shares Rise Ahead of FDA Decision on Blood Cancer Drug

MT Newswires Live

Jul 15, 2025

GSK (GSK) shares rose in early trading on Tuesday after the US Food and Drug Administration published documents related to a potential approval of the company's blood cancer drug, Bloomberg reported.

The FDA's Oncologic Drugs Advisory Committee is scheduled to meet on Thursday to discuss GSK's Blenrep, Bloomberg reported, adding that a decision on approval of the drug is expected by July 23.

Blenrep has been approved in the UK in combination with other oncology drugs to treat certain patients with multiple myeloma, an incurable blood cancer, Bloomberg reported.

GSK shares were 0.7% higher in recent trading.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 38.54, Change: +0.24, Percent Change: +0.63

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2551198964"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2551198964\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2551198964?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-15 21:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2551198964","market":"sg","top_or_hot":-1,"title":"Market Chatter: GSK Shares Rise Ahead of FDA Decision on Blood Cancer Drug","media":"MT Newswires Live","content":"<html><body><p> GSK (GSK) shares rose in early trading on Tuesday after the US Food and Drug Administration published documents related to a potential approval of the company's blood cancer drug, Bloomberg reported.</p><p>The FDA's Oncologic Drugs Advisory Committee is scheduled to meet on  Thursday to discuss GSK's Blenrep, Bloomberg reported, adding that a decision on approval of the drug is expected by July 23.</p><p>Blenrep has been approved in the UK in combination with other oncology drugs to treat certain patients with multiple myeloma, an incurable blood cancer, Bloomberg reported.</p><p>GSK shares were 0.7% higher in recent trading.</p><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p><p>Price: 38.54, Change: +0.24, Percent Change: +0.63</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market Chatter: GSK Shares Rise Ahead of FDA Decision on Blood Cancer Drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket Chatter: GSK Shares Rise Ahead of FDA Decision on Blood Cancer Drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-07-15 21:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> GSK (GSK) shares rose in early trading on Tuesday after the US Food and Drug Administration published documents related to a potential approval of the company's blood cancer drug, Bloomberg reported.</p><p>The FDA's Oncologic Drugs Advisory Committee is scheduled to meet on  Thursday to discuss GSK's Blenrep, Bloomberg reported, adding that a decision on approval of the drug is expected by July 23.</p><p>Blenrep has been approved in the UK in combination with other oncology drugs to treat certain patients with multiple myeloma, an incurable blood cancer, Bloomberg reported.</p><p>GSK shares were 0.7% higher in recent trading.</p><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p><p>Price: 38.54, Change: +0.24, Percent Change: +0.63</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GSK.UK","symbol_name":"葛兰素史克","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2551198964","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2551198964","pubTimestamp":1752587914,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"GSK  shares rose in early trading on Tuesday after the US Food and Drug Administration published documents related to a potential approval of the company's blood cancer drug, Bloomberg reported.The FDA's Oncologic Drugs Advisory Committee is scheduled to meet on  Thursday to discuss GSK's Blenrep, Bloomberg reported, adding that a decision on approval of the drug is expected by July 23.Blenrep has been approved in the UK in combination with other oncology drugs to treat certain patients with multiple myeloma, an incurable blood cancer, Bloomberg reported.GSK shares were 0.7% higher in recent trading.Price: 38.54, Change: +0.24, Percent Change: +0.63","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GSK.UK":"葛兰素史克","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4007":"制药","GSK":"葛兰素史克","BK4532":"文艺复兴科技持仓","LU1829250122.USD":"高盛欧洲核心股票组合Acc"},"translate_title":"市场热议：在FDA对血癌药物做出决定之前，葛兰素史克股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GSK.UK":0.6,"GSK":1},"content_text":"GSK (GSK) shares rose in early trading on Tuesday after the US Food and Drug Administration published documents related to a potential approval of the company's blood cancer drug, Bloomberg reported.The FDA's Oncologic Drugs Advisory Committee is scheduled to meet on  Thursday to discuss GSK's Blenrep, Bloomberg reported, adding that a decision on approval of the drug is expected by July 23.Blenrep has been approved in the UK in combination with other oncology drugs to treat certain patients with multiple myeloma, an incurable blood cancer, Bloomberg reported.GSK shares were 0.7% higher in recent trading.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: 38.54, Change: +0.24, Percent Change: +0.63","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}